T-Cell mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ.
The DOI matches its Crossref record; 29 of the 31 references it cites were found in a registry or an index.
Abstract
Bone resorption is regulated by the immune system, where T-cell expression of RANKL (receptor activator of nuclear factor (NF)-kappaB ligand), a member of the tumour-necrosis factor family that is essential for osteoclastogenesis, may contribute to pathological conditions, such as autoimmune arthritis. However, whether activated T cells maintain bone homeostasis by counterbalancing the action of RANKL remains unknown. Here we show that T-cell production of interferon (IFN)-gamma strongly suppresses osteoclastogenesis by interfering with the RANKL-RANK signalling pathway. IFN-gamma induces rapid degradation of the RANK adapter protein, TRAF6 (tumour necrosis factor receptor-associated factor 6), which results in strong inhibition of the RANKL-induced activation of the transcription factor NF-kappaB and JNK. This inhibition of osteoclastogenesis is rescued by overexpressing TRAF6 in precursor cells, which indicates that TRAF6 is the target critical for the IFN-gamma action. Furthermore, we provide evidence that the accelerated degradation of TRAF6 requires both its ubiquitination, which is initiated by RANKL, and IFN-gamma-induced activation of the ubiquitin-proteasome system. Our study shows that there is cross-talk between the tumour necrosis factor and IFN families of cytokines, through which IFN-gamma provides a negative link between T-cell activation and bone resorption. Our results may offer a therapeutic approach to treat the inflammation-induced tissue breakdown.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Synovial cells isolated from rheumatoid joints have been found to express RANKL, RANK, and OPG (90, 412-415).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [415]
Citations
Cites
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,228
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., & Martin, T. J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0367 · Cited by 2,336
Kong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., et al. (1999) · Nature · doi:10.1038/46303 · Cited by 1,856
Meraz, M. A., White, J. M., Sheehan, K. C. F., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81288-x · Cited by 1,656
Immune Response in Mice that Lack the Interferon-γ Receptor
Huang, S., Hendriks, W., Althage, A., Hemmi, S., Bluethmann, H., Kamijo, R., Vilček, J., Zinkernagel, R. M., & Aguet, M. (1993) · Science · doi:10.1126/science.8456301 · Cited by 1,548
The Proteasome: Paradigm of a Self-Compartmentalizing Protease
Baumeister, W., Walz, J., Zühl, F., & Seemüller, E. (1998) · Cell · doi:10.1016/s0092-8674(00)80929-0 · Cited by 1,494
TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling
Lomaga, M. A., Yeh, W.-C., Sarosi, I., Duncan, G. S., Furlonger, C., Ho, A., Morony, S., Capparelli, C., Van, G., Kaufman, S., et al. (1999) · Genes & Development · doi:10.1101/gad.13.8.1015 · Cited by 1,267
Matsuyama, T., Kimura, T., Kitagawa, M., Pfeffer, K., Kawakami, T., Watanabe, N., Kündig, T. M., Amakawa, R., Kishihara, K., Wakeham, A., et al. (1993) · Cell · doi:10.1016/s0092-8674(05)80086-8 · Cited by 649
Self-citation
Research works printed but not linked: 2
- Takayanagi, H. et al. Involvement of receptor activator of nuclear factor κB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum. 43, 259–269 (2000). · doi:10.1002/1529-0131(200002)43:2<259::aid-anr4>3.0.co;2-w
- Gravallese, E. M. et al. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum. 43, 250–258 (2000). · doi:10.1002/1529-0131(200002)43:2<250::aid-anr3>3.0.co;2-p
Cited by
Items 101–200 of 1,001
Wong, P. K. K., Quinn, J. M. W., Sims, N. A., van Nieuwenhuijze, A., Campbell, I. K., & Wicks, I. P. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21537 · Cited by 270
Giuliani, N., Colla, S., Sala, R., Moroni, M., Lazzaretti, M., La Monica, S., Bonomini, S., Hojden, M., Sammarelli, G., Barillè, S., et al. (2002) · Blood · doi:10.1182/blood-2002-04-1121 · Cited by 270
The role of cytokines in inflammatory bone loss
Souza, P. P. C., & Lerner, U. H. (2013) · Immunological Investigations · doi:10.3109/08820139.2013.822766 · Cited by 269
Inflammatory bone destruction and osteoimmunology
Takayanagi, H. (2005) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2005.00814.x · Cited by 270
Self-citationBharti, A. C., Takada, Y., & Aggarwal, B. B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.5940 · Cited by 268
Weitzmann, M. N. (2013) · Scientifica · doi:10.1155/2013/125705 · Cited by 259
The Central Role of Wear Debris in Periprosthetic Osteolysis
Purdue, P. E., Koulouvaris, P., Nestor, B. J., & Sculco, T. P. (2006) · HSS Journal®: The Musculoskeletal Journal of Hospital for Special Surgery · doi:10.1007/s11420-006-9003-6 · Cited by 258
K63 Polyubiquitination and Activation of mTOR by the p62-TRAF6 Complex in Nutrient-Activated Cells
Linares, J. F., Duran, A., Yajima, T., Pasparakis, M., Moscat, J., & Diaz-Meco, M. T. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.06.020 · Cited by 256
Updating osteoimmunology: regulation of bone cells by innate and adaptive immunity
Walsh, M. C., Takegahara, N., Kim, H., & Choi, Y. (2018) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.213 · Cited by 252
Ruocco, M. G., Maeda, S., Park, J. M., Lawrence, T., Hsu, L.-C., Cao, Y., Schett, G., Wagner, E. F., & Karin, M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042081 · Cited by 252
Roles of Mitogen-Activated Protein Kinases in Osteoclast Biology
Lee, K., Seo, I., Choi, M. H., & Jeong, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103004 · Cited by 251
Inflammatory osteolysis: A conspiracy against bone
Mbalaviele, G., Novack, D. V., Schett, G., & Teitelbaum, S. L. (2017) · Journal of Clinical Investigation · doi:10.1172/jci93356 · Cited by 251
The haematoma and its role in bone healing
Schell, H., Duda, G. N., Peters, A., Tsitsilonis, S., Johnson, K. A., & Schmidt‐Bleek, K. (2017) · Journal of Experimental Orthopaedics · doi:10.1186/s40634-017-0079-3 · Cited by 246
Physiological and pathophysiological bone turnover — role of the immune system
Weitzmann, M. N., & Ofotokun, I. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.91 · Cited by 240
Li, H., Hong, S., Qian, J., Zheng, Y., Yang, J., & Yi, Q. (2010) · Blood · doi:10.1182/blood-2009-11-255026 · Cited by 239
The Role of the Immune Microenvironment in Bone Regeneration
Yang, N., & Liu, Y. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.61080 · Cited by 238
Macrophage-Osteoclast Associations: Origin, Polarization, and Subgroups
Sun, Y., Li, J., Xie, X., Gu, F., Sui, Z., Zhang, K., & Yu, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.778078 · Cited by 233
Osteoclast precursors, RANKL/RANK, and immunology
Xing, L., Schwarz, E. M., & Boyce, B. F. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00336.x · Cited by 231
The Interplay Between Monocytes/Macrophages and CD4+ T Cell Subsets in Rheumatoid Arthritis
Roberts, C. A., Dickinson, A. K., & Taams, L. S. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00571 · Cited by 229
The Macrophage-Osteoclast Axis in Osteoimmunity and Osteo-Related Diseases
Yao, Y., Cai, X., Ren, F., Ye, Y., Wang, F., Zheng, C., Qian, Y., & Zhang, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.664871 · Cited by 224
New developments in osteoimmunology
Takayanagi, H. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.167 · Cited by 228
Self-citationGenetic control of skeletal development
Wagner, E. F., & Karsenty, G. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00228-8 · Cited by 229
T-Cell Mediated Inflammation in Postmenopausal Osteoporosis
Wu, D., Cline-Smith, A., Shashkova, E., Perla, A., Katyal, A., & Aurora, R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.687551 · Cited by 227
Immunoporosis: Role of Innate Immune Cells in Osteoporosis
Saxena, Y., Routh, S., & Mukhopadhaya, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.687037 · Cited by 222
Effects of the IL-23–IL-17 pathway on bone in spondyloarthritis
Gravallese, E. M., & Schett, G. (2018) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0091-8 · Cited by 223
Osteoclasts, rheumatoid arthritis, and osteoimmunology
Sato, K., & Takayanagi, H. (2006) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000231912.24740.a5 · Cited by 223
Self-citationRole of RANKL and RANK in bone loss and arthritis
Jones, D. H., Kong, Y.-Y., & Penninger, J. M. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.suppl_2.ii32 · Cited by 223
Macrophages and bone inflammation
Gu, Q., Yang, H., & Shi, Q. (2017) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2017.05.002 · Cited by 221
RANKing Intracellular Signaling in Osteoclasts
Feng, X. (2005) · IUBMB Life (International Union of Biochemistry and Molecular Biology: Life) · doi:10.1080/15216540500137669 · Cited by 219
Harnessing and Modulating Inflammation in Strategies for Bone Regeneration
Mountziaris, P. M., Spicer, P. P., Kasper, F. K., & Mikos, A. G. (2011) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2011.0182 · Cited by 217
Osteoimmunology: Crosstalk Between the Immune and Bone Systems
Nakashima, T., & Takayanagi, H. (2009) · Journal of Clinical Immunology · doi:10.1007/s10875-009-9316-6 · Cited by 216
Self-citationDhodapkar, M. V., Krasovsky, J., Osman, K., & Geller, M. D. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20031030 · Cited by 217
HOROWITZ, M., XI, Y., WILSON, K., & KACENA, M. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00030-7 · Cited by 217
LIU, W., & ZHANG, X. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3152 · Cited by 216
Kim, M. S., Yang, Y.-M., Son, A., Tian, Y. S., Lee, S.-I., Kang, S. W., Muallem, S., & Shin, D. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.051557 · Cited by 208
Porphyromonas gingivalis promotes Th17 inducing pathways in chronic periodontitis
Moutsopoulos, N. M., Kling, H. M., Angelov, N., Jin, W., Palmer, R. J., Nares, S., Osorio, M., & Wahl, S. M. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.03.003 · Cited by 209
The potential role of interleukin‐17 in the immunopathology of periodontal disease
Takahashi, K., Azuma, T., Motohira, H., Kinane, D. F., & Kitetsu, S. (2005) · Journal of Clinical Periodontology · doi:10.1111/j.1600-051x.2005.00676.x · Cited by 208
Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF‐κB
Habelhah, H., Takahashi, S., Cho, S., Kadoya, T., Watanabe, T., & Ronai, Z. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600044 · Cited by 207
“Interestingly, Siah2-mediated degradation of TRAF2 takes place within 2–6 h after exposure to stress stimuli, similar to what was observed for TRAF6 (Takayanagi et al, 2000).”
BackgroundResultXie, Y., Hu, C., Feng, Y., Li, D., Ai, T., Huang, Y., Chen, X., Huang, L., & Tan, J. (2020) · Regenerative Biomaterials · doi:10.1093/rb/rbaa006 · Cited by 205
Regulatory T Cells Protect from Local and Systemic Bone Destruction in Arthritis
Zaiss, M. M., Frey, B., Hess, A., Zwerina, J., Luther, J., Nimmerjahn, F., Engelke, K., Kollias, G., Hünig, T., Schett, G., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903841 · Cited by 205
Type II collagen autoimmunity in a mouse model of human rheumatoid arthritis
Cho, Y.-G., Cho, M.-L., Min, S.-Y., & Kim, H.-Y. (2007) · Autoimmunity Reviews · doi:10.1016/j.autrev.2007.08.001 · Cited by 202
Osteoimmunology and the influence of pro-inflammatory cytokines on osteoclasts
Zupan, J., Jeras, M., & Marc, J. (2013) · Biochemia Medica · doi:10.11613/bm.2013.007 · Cited by 202
Walsh, M. C., & Choi, Y. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(03)00027-3 · Cited by 200
Evans, K. E., & Fox, S. W. (2007) · BMC Cell Biology · doi:10.1186/1471-2121-8-4 · Cited by 198
Kim, Y., Sato, K., Asagiri, M., Morita, I., Soma, K., & Takayanagi, H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505820200 · Cited by 198
Self-citationChronic Implant-Related Bone Infections—Can Immune Modulation be a Therapeutic Strategy?
Seebach, E., & Kubatzky, K. F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01724 · Cited by 198
Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis
Söderström, K., Stein, E., Colmenero, P., Purath, U., Müller-Ladner, U., Teixeira de Matos, C., Tarner, I. H., Robinson, W. H., & Engleman, E. G. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000546107 · Cited by 196
Dar, H. Y., Shukla, P., Mishra, P. K., Anupam, R., Mondal, R. K., Tomar, G. B., Sharma, V., & Srivastava, R. K. (2018) · Bone Reports · doi:10.1016/j.bonr.2018.02.001 · Cited by 194
Osteoprotegerin diminishes advanced bone cancer pain.
Luger, N. M., Honoré, P., Sabino, M., Schwei, M. J., Rogers, S. D., Mach, D. B., Clohisy, D. R., & Mantyh, P. W. (2001) · PubMed · Cited by 211
The role of T lymphocytes in bone metabolism
Weitzmann, M. N., & Pacifici, R. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00324.x · Cited by 192
The Interplay between the Bone and the Immune System
Mori, G., D'Amelio, P., Faccio, R., & Brunetti, G. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/720504 · Cited by 193
Yago, T., Nanke, Y., Kawamoto, M., Furuya, T., Kobashigawa, T., Kamatani, N., & Kotake, S. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2297 · Cited by 193
Interplay between interferon and other cytokine systems in bone metabolism
Takayanagi, H., Sato, K., Takaoka, A., & Taniguchi, T. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00337.x · Cited by 191
Self-citationOsteoimmunology: A Current Update of the Interplay Between Bone and the Immune System
Guder, C., Gravius, S., Burger, C., Wirtz, D. C., & Schildberg, F. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00058 · Cited by 190
Lei, H., Schmidt-Bleek, K., Dienelt, A., Reinke, P., & Volk, H.-D. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00184 · Cited by 186
Dynamic visualization of RANKL and Th17-mediated osteoclast function
Kikuta, J., Wada, Y., Kowada, T., Wang, Z., Sun-Wada, G.-H., Nishiyama, I., Mizukami, S., Maiya, N., Yasuda, H., Kumanogoh, A., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65054 · Cited by 189
Overlapping Protective and Destructive Regulatory Pathways in Apical Periodontitis
Márton, I. J., & Kiss, C. (2014) · Journal of Endodontics · doi:10.1016/j.joen.2013.10.036 · Cited by 187
The Potential of Probiotics as a Therapy for Osteoporosis
Collins, F. L., Rios-Arce, N. D., Schepper, J. D., Parameswaran, N., & McCabe, L. R. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.bad-0015-2016 · Cited by 184
Cappellen, D., Luong-Nguyen, N.-H., Bongiovanni, S., Grenet, O., Wanke, C., & Šuša, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200434200 · Cited by 184
How interferon-γ keeps autoimmune diseases in check
Kelchtermans, H., Billiau, A., & Matthys, P. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.07.002 · Cited by 184
Osteoclasts promote immune suppressive microenvironment in multiple myeloma: therapeutic implication
An, G., Acharya, C., Feng, X., Wen, K., Zhong, M., Zhang, L., Munshi, N. C., Qiu, L., Tai, Y.-T., & Anderson, K. C. (2016) · Blood · doi:10.1182/blood-2016-03-707547 · Cited by 184
The Involvement of IL-23 and the Th17 Pathway in Periodontitis
Ohyama, H., Kato-Kogoe, N., Kuhara, A., Nishimura, F., Nakasho, K., Yamanegi, K., Yamada, N., Hata, M., Yamane, J., & Terada, N. (2009) · Journal of Dental Research · doi:10.1177/0022034509339889 · Cited by 182
Cadosch, D., Chan, E., Gautschi, O. P., & Filgueira, L. (2009) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.32625 · Cited by 180
Boon and Bane of Inflammation in Bone Tissue Regeneration and Its Link with Angiogenesis
Schmidt-Bleek, K., Kwee, B. J., Mooney, D. J., & Duda, G. N. (2015) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2014.0677 · Cited by 181
Osteoclastogenesis, Bone Resorption, and Osteoclast-Based Therapeutics
Zaidi, M., Blair, H. C., Moonga, B. S., Abe, E., & Huang, C. L.-H. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.4.599 · Cited by 180
Weitzmann, M. N. (2017) · Toxicologic Pathology · doi:10.1177/0192623317735316 · Cited by 177
Estrogen prevents bone loss through transforming growth factor β signaling in T cells
Gao, Y., Qian, W.-P., Dark, K., Toraldo, G., Lin, A. S. P., Guldberg, R. E., Flavell, R. A., Weitzmann, M. N., & Pacifici, R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404888101 · Cited by 177
Changing expression profiles of lncRNAs, mRNAs, circRNAs and miRNAs during osteoclastogenesis
Dou, C., Cao, Z., Yang, B., Ding, N., Hou, T., Luo, F., Kang, F., Li, J., Yang, X., Jiang, H., et al. (2016) · Scientific Reports · doi:10.1038/srep21499 · Cited by 176
Bozec, A., Zaiss, M. M., Kagwiria, R., Voll, R., Rauh, M., Chen, Z., Mueller-Schmucker, S., Kroczek, R. A., Heinzerling, L., Moser, M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007764 · Cited by 175
Walsh, M. C., Kim, G. K., Maurizio, P. L., Molnar, E. E., & Choi, Y. (2008) · PLoS ONE · doi:10.1371/journal.pone.0004064 · Cited by 175
Chemokines in Physiological and Pathological Bone Remodeling
Brylka, L. J., & Schinke, T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02182 · Cited by 172
Blimp1-mediated repression of negative regulators is required for osteoclast differentiation
Nishikawa, K., Nakashima, T., Hayashi, M., Fukunaga, T., Kato, S., Kodama, T., Takahashi, S., Calame, K., & Takayanagi, H. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912779107 · Cited by 170
Self-citationMaintaining homeostatic control of periodontal bone tissue
Hathaway‐Schrader, J. D., & Novince, C. M. (2021) · Periodontology 2000 · doi:10.1111/prd.12368 · Cited by 167
Chen, Z., Bachhuka, A., Wei, F., Wang, X., Liu, G., Vasilev, K., & Xiao, Y. (2017) · Nanoscale · doi:10.1039/c7nr05913b · Cited by 169
Discoveries, drugs and skeletal disorders
Goltzman, D. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd916 · Cited by 168
Interferon-γ plays a role in bone formation in vivo and rescues osteoporosis in ovariectomized mice
Duque, G., Huang, D. C., Dion, N., Macoritto, M., Rivas, D., Li, W., Yang, X. F., Li, J., Lian, J., Marino, F. T., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.350 · Cited by 167
Signaling crosstalk between RANKL and interferons in osteoclast differentiation.
Takayanagi, H., Kim, S., & Taniguchi, T. (2002) · Arthritis Research · doi:10.1186/ar581 · Cited by 181
Self-citationInflammatory arthritis increases mouse osteoclast precursors with myeloid suppressor function
Charles, J. F., Hsu, L.-Y., Niemi, E. C., Weiss, A., Aliprantis, A. O., & Nakamura, M. C. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60920 · Cited by 164
Immunoproteasome assembly and antigen presentation in mice lacking both PA28alpha and PA28beta
Murata, S. (2001) · The EMBO Journal · doi:10.1093/emboj/20.21.5898 · Cited by 163
Self-citationControl of RANKL gene expression
O'Brien, C. A. (2010) · Bone · doi:10.1016/j.bone.2009.08.050 · Cited by 162
Osteoimmunology: Interactions of the Immune and Skeletal Systems
Rho, J., Takami, M., & Choi, Y. (2004) · Molecules and Cells · doi:10.1016/s1016-8478(23)12997-9 · Cited by 162
Osteoimmunology: Inflammatory osteolysis and regeneration of the alveolar bone
Gruber, R. (2019) · Journal of Clinical Periodontology · doi:10.1111/jcpe.13056 · Cited by 159
Activated CD4+CD25+ regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis
Kelchtermans, H., Geboes, L., Mitera, T., Huskens, D., Leclercq, G., & Matthys, P. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.086066 · Cited by 160
Interferon-Gamma-Mediated Osteoimmunology
Tang, M., Tian, L., Luo, G., & Yu, X. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01508 · Cited by 159
Ji, J.-D., Park-Min, K.-H., Shen, Z., Fajardo, R. J., Goldring, S. R., McHugh, K. P., & Ivashkiv, L. B. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900072 · Cited by 157
Do RANKL inhibitors (denosumab) affect inflammation and immunity?
Ferrari, S., & Ferrari, S. (2010) · Osteoporosis International · doi:10.1007/s00198-010-1326-y · Cited by 170
Sapra, L., Dar, H. Y., Bhardwaj, A., Pandey, A., Kumari, S., Azam, Z., Upmanyu, V., Anwar, A., Shukla, P., Mishra, P. K., et al. (2021) · Scientific Reports · doi:10.1038/s41598-020-80536-2 · Cited by 160
Takahashi, N., Matsumoto, K., Saito, H., Nanki, T., Miyasaka, N., Kobata, T., Azuma, M., Lee, S., Mizutani, S., & Morio, T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803256 · Cited by 173
Fakruddin, J. M., & Laurence, J. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304676200 · Cited by 175
Coordinate regulation of cell growth and differentiation by TGF-β superfamily and Runx proteins
Miyazono, K., Maeda, S., & Imamura, T. (2004) · Oncogene · doi:10.1038/sj.onc.1207131 · Cited by 182
The multifaceted roles of TRAFs in the regulation of B-cell function
Bishop, G. A. (2004) · Nature reviews. Immunology · doi:10.1038/nri1462 · Cited by 188
Osteoclast signalling pathways
Blair, H. C., Robinson, L. J., & Zaidi, M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.077 · Cited by 173
Balance of inflammatory response in stable gingivitis and progressive periodontitis lesions
Honda, T., Domon, H., Okui, T., Kajita, K., Amanuma, R., & Yamazaki, K. (2006) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2006.03028.x · Cited by 154
Ivashkiv, L. B., & Hu, X. (2004) · Arthritis Research · doi:10.1186/ar1197 · Cited by 188
Advances in osteoclast biology reveal potential new drug targets and new roles for osteoclasts
Boyce, B. F. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1885 · Cited by 149
LMP1 TRAFficking Activates Growth and Survival pathways
Soni, V., Cahir-McFarland, E. D., & Kieff, E. D. (2007) · Springer eBooks · doi:10.1007/978-0-387-70630-6_14 · Cited by 153
Proinflammatory and immunoregulatory mechanisms in periapical lesions
Čolić, M. J., Gazivoda, D., Vučević, D., Vasilijić, S., Rudolf, R., & Lukić, A. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.01.011 · Cited by 153
Rossi, F., Siniscalco, D., Luongo, L., PETROCELLIS, L. D., Bellini, G., Petrosino, S., Torella, M., Santoro, C., Nobili, B., Perrotta, S., et al. (2008) · Bone · doi:10.1016/j.bone.2008.10.056 · Cited by 155
Maeda, K., Yoshida, K., Nishizawa, T., Otani, K., Yamashita, Y., Okabe, H., Hadano, Y., Kayama, T., Kurosaka, D., & Saito, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052871 · Cited by 161
Man, T.-K., Lu, X.-Y., Jaeweon, K., Perlaky, L., Harris, C. P., Shah, S., Ladanyi, M., Gorlick, R., Lau, C. C., & Rao, P. H. (2004) · BMC Cancer · doi:10.1186/1471-2407-4-45 · Cited by 148
Metadata
- Authors
- Takayanagi, H., Ogasawara, K., Hida, S., Chiba, T., Murata, S., Sato, K., Takaoka, A., Yokochi, T., Oda, H., Tanaka, K., Nakamura, K., & Taniguchi, T.
- Affiliations
- The University of Tokyo (JP)
- Tokyo Metropolitan Institute of Medical Science (JP)
- Corresponding author
- Taniguchi, Tadatsugu
- ORCID
- Venue
- Nature
- Published
- 2000-11
- Volume
- 408
- Issue
- 6812
- Pages
- 600-605
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1639854378
- Cited by
- 1,358
- References
- 31
- Citations by year
- 2026: 34 · 2025: 41 · 2024: 45 · 2023: 47 · 2022: 51 · 2021: 68 · 2020: 66 · 2019: 45 · 2018: 48 · 2017: 51 · 2016: 47 · 2015: 46 · 2014: 41 · 2013: 56 · 2012: 50
- FWCI
- 15.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Japan Society for the Promotion of Science
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- osteoclastogenesis, RANKL, interferon-gamma, T cells, TRAF6, NF-κB, JNK, ubiquitination, ubiquitin-proteasome system, bone resorption, bone homeostasis, autoimmune arthritis
- MeSH terms
- Animals, Arthritis, Autoantigens, Autoimmune Diseases, Bone Marrow Cells, Bone Resorption, Carrier Proteins, Cells, Cultured, Cysteine Endopeptidases, Glycoproteins, Interferon-gamma, Lymphocyte Activation, Macrophages, Membrane Glycoproteins, Mice, Inbred C57BL, Multienzyme Complexes, Osteoclasts, Proteins, T-Lymphocytes, Ubiquitins, Signal Transduction, NF-kappa B, Receptors, Tumor Necrosis Factor, Receptors, Cytoplasmic and Nuclear, Coculture Techniques, Mitogen-Activated Protein Kinase Kinases, Proteasome Endopeptidase Complex, TNF Receptor-Associated Factor 6, JNK Mitogen-Activated Protein Kinases, MAP Kinase Kinase 4, Mice, Osteoprotegerin, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.